Section Editors

Elias Jabbour - University of Texas MD Anderson Cancer Center

Elias Jabbour

University of Texas MD Anderson Cancer Center

Dr. Elias Jabbour graduated from the Saint Joseph’s School of Medicine in 1998 and joined, thereafter, the Hotel Dieu de France University Hospital as a resident. In 2001, he pursued in fellowship in Hematology-Oncology at the Gustave Roussy Institute. In 2003, he joined the University of Texas M. D. Anderson Cancer as a fellow in the Department of Hematology/Leukemia and Stem cell transplantation. Thereafter, in 2007, he joined the faculty in the Leukemia department as Assistant Professor. Dr. Jabbour is actively involved in research in both acute and chronic forms of leukemia. He was actively involved in clinical trials that lead to the approval of several drugs in chronic myeloid leukemia (CML) and myelodysplastic syndromes. His research on resistance to imatinib and mutations of the protein kinase domain were presented in several international; meetings and published in peer-reviewed journals. He is also developing tailored therapies to CML.

Michele Baccarani - Head, Institute of Hematology and Medical Oncology, “L and A Sercignoli”, S Orsala University Hospital, Professor of Hematology, University of Bologna

Michele Baccarani

Head, Institute of Hematology and Medical Oncology, “L and A Sercignoli”, S Orsala University Hospital, Professor of Hematology, University of Bologna

Prof. Baccarani is Chairman of the Gruppo Italiano Malattie EMatologiche dell’Adulto (GIMEMA) chronic myeloid leukaemia (CML) Working Party (formerly the Italian Cooperative Study Group on CML) and of the CML working group of the European LeukemiaNet.

Prof. Baccarani is the first or contributing author on over 600 publications in the field of haematology.

Previously, he was Professor of Haematology at the University of Bologna and Head of the Department of Haematology and Oncology ‘L and A Seràgnoli’ at the S Orsola-Malpighi University Hospital, Bologna until November 2012. He headed the Division of Haematology and Bone Marrow Transplantation of Udine University Hospital during his post as a Professor of Haematology at Udine University. He has also held faculty positions as a Professor of Haematology at Trieste University and of Cancer Chemotherapy at Chieti University.

He is Past President of both the Italian Society of Haematology and the Italian Society of Experimental Haematology

Latest Articles

Latest Videos

Video List based on Category on Node Page

Latest Videos

The Annual Meeting of the European Society for Blood and Marrow Transplantation is the premiere event for blood and marrow transplantation and cell therapy. Take a look at what the conference has to offer and what's coming up at the 2017 meeting. EBMT 2017 runs from 26-29 March 2017, in Marseille, France. This video has been included on the touchONCOLOGY.com website with permission from...
Dr Shaji Kumar reviews the rationale for targeting the BCL-2 protein in multiple myeloma (MM) and the results of the recent phase I study of venetoclax. He also discusses selinexor combination therapy and the role of minimal residual disease in assessing response to therapies. FILMED AT THE AMERICAN SOCIETY OF HEMATOLOGY (ASH) ANNUAL MEETING 2016, SAN DIEGO, CALIFORNIA, US Dr Shaji Kumar has...
Dr Mohamad Mohty discusses consolidation and maintenance therapy in multiple myeloma and whether these therapies can replace autologous stem cell transplantation (ASCT). FILMED AT THE AMERICAN SOCIETY OF HEMATOLOGY (ASH) ANNUAL MEETING 2016, SAN DIEGO, CALIFORNIA, US